Juliana Fernandes1, Cristiano Dos Santos Gomes2, Ricardo Oliveira Guerra2, Catherine M Pirkle3, Afshin Vafaei4, Carmen-Lucia Curcio5, Armèle Dornelas de Andrade6. 1. Physical Therapy Department, Universidade Federal de Pernambuco, Recife, Brazil. Electronic address: julianaferso@gmail.com. 2. Physical Therapy Department, Universidade Federal do Rio Grande do Norte, Natal, Brazil. 3. Health Policy and Management Office of Public Health Studies, University of Hawai'i at Manoa, Honolulu, Hawaii, USA. 4. Department of Health Sciences, Lakehead University, Ontario, Canada. 5. Health Sciences Faculty, Universidad de Caldas, Manizales, Colombia. 6. Physical Therapy Department, Universidade Federal de Pernambuco, Recife, Brazil.
Abstract
OBJECTIVE: To investigate the association between frailty and a summary cardiovascular risk measure (Framingham Risk Score, FRS) in a sample of older adults from different epidemiologic contexts participating in the multicenter International Mobility in Aging Study (IMIAS). MATERIAL AND METHODS: This cross-sectional study used data from the IMIAS, which is composed of older adults from four different countries (Canada, Albania, Colombia and Brazil). A total of 1724 older adults aged 65-74 years were assessed. Frailty was defined as the presence of 3 or more of the following criteria: unintentional weight loss in the last year, exhaustion, muscle weakness, slowness in gait speed, and low levels of physical activity. The FRS was calculated to estimate the 10-year risk for cardiovascular disease (CVD), based on: sex, age, systolic blood pressure (SBP), and treatment for hypertension, total and high-density lipoprotein (HDL) cholesterol, diabetes mellitus status and smoking habits. Confounders included measures of childhood social and economic adversity, as well as mid-life and adult adversity. RESULTS: After adjustment for adversities which occurred during in early, adult or current life, frail individuals presented higher FRS values (β = 3.81, 95 %CI: 0.97-6.65, p-value <0.001) when compared to robust participants. A statistically significant relationship was also observed in prefrail participants with FRS (β = 1.61, 95 % CI: 0.72-3.02, p-value <0.05). CONCLUSION: Frailty and prefrailty were associated to FRS, independent of life course adversities. Screening cardiovascular risk factors should be a target, mainly in those who present frailty syndrome.
OBJECTIVE: To investigate the association between frailty and a summary cardiovascular risk measure (Framingham Risk Score, FRS) in a sample of older adults from different epidemiologic contexts participating in the multicenter International Mobility in Aging Study (IMIAS). MATERIAL AND METHODS: This cross-sectional study used data from the IMIAS, which is composed of older adults from four different countries (Canada, Albania, Colombia and Brazil). A total of 1724 older adults aged 65-74 years were assessed. Frailty was defined as the presence of 3 or more of the following criteria: unintentional weight loss in the last year, exhaustion, muscle weakness, slowness in gait speed, and low levels of physical activity. The FRS was calculated to estimate the 10-year risk for cardiovascular disease (CVD), based on: sex, age, systolic blood pressure (SBP), and treatment for hypertension, total and high-density lipoprotein (HDL) cholesterol, diabetes mellitus status and smoking habits. Confounders included measures of childhood social and economic adversity, as well as mid-life and adult adversity. RESULTS: After adjustment for adversities which occurred during in early, adult or current life, frail individuals presented higher FRS values (β = 3.81, 95 %CI: 0.97-6.65, p-value <0.001) when compared to robust participants. A statistically significant relationship was also observed in prefrail participants with FRS (β = 1.61, 95 % CI: 0.72-3.02, p-value <0.05). CONCLUSION: Frailty and prefrailty were associated to FRS, independent of life course adversities. Screening cardiovascular risk factors should be a target, mainly in those who present frailty syndrome.
Authors: Gal Sella; Gera Gandelman; Ortal Tuvali; Igor Volodarsky; Valeri Cuciuc; Dan Haberman; Omar Ayyad; Lion Poles; Michael Welt; Oscar Horacio Kracoff; Jacob George Journal: J Clin Med Date: 2022-05-06 Impact factor: 4.964
Authors: Marta Kałużna-Oleksy; Agata Kukfisz; Jacek Migaj; Magdalena Dudek; Helena Krysztofiak; Filip Sawczak; Magdalena Szczechla; Katarzyna Przytarska; Ewa Straburzyńska-Migaj; Marta Wleklik; Izabella Uchmanowicz Journal: J Clin Med Date: 2021-12-19 Impact factor: 4.241
Authors: Abdulla A Damluji; Shang-En Chung; Qian-Li Xue; Rani K Hasan; Mauro Moscucci; Daniel E Forman; Karen Bandeen-Roche; Wayne Batchelor; Jeremy D Walston; Jon R Resar; Gary Gerstenblith Journal: Eur Heart J Date: 2021-10-01 Impact factor: 35.855
Authors: Nicholas R Evans; Oliver M Todd; Jatinder S Minhas; Patricia Fearon; George W Harston; Jonathan Mant; Gillian Mead; Jonathan Hewitt; Terence J Quinn; Elizabeth A Warburton Journal: Int J Stroke Date: 2021-08-04 Impact factor: 5.266